(Q68495883)

English

A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group

scientific article published on 01 February 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

phase III clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

language of work or name

0 references

publication date

1 February 1990

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

61

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

311-315

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

The role of chemotherapy in the management of cancer of the head and neck: A review

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase II

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: The head and neck contracts program

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of oncogene expression in head and neck tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of ploidy in laryngeal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2178667

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1990.59

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2178667%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68495883&oldid=2222579726"